The 23rd Annual Biotech & Pharmaceutical Patenting 2015 is a conference that covers topics such as:
- Patenting genes and theranostics including HGS v Lilly
- Developments in European patent law in the last 12 months
- Product launch strategies and preliminary injunctions including the Solvay case
- Dealing with competition law issues in patenting
- The Unified Patent Court – what will the impact be?
- Planning for patent expiry and managing innovation
- Strategies for maximising patent life cycles - exploring the application of SPCs to extend patents
- SPCs masterclass - recent case law and varying requirements around Europe including an analysis of the impact of Neurim
The 23rd Annual Biotech & Pharmaceutical Patenting 2015 brings together:
- Patent Attorneys and Agents
- Biotech and Pharma Companies: In-house Counsel, Patent Attorneys, IP Managers, Legal Advisors, Patent Advisors, Chief IP Counsel, IP Directors, Scientific Researchers, CEOs and Corporate Management
- Intellectual Property Consultants
- Intellectual Property Lawyers
- Academics
- Examiners
